Teva acquires Emalex Biosciences for up to $900m Globes – Israel Business NewsTeva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy Yahoo FinanceTeva to acquire Emalex for $700M plus milestone payments By Investing.com Investing.com CanadaTeva (TEVA) Announces Acquisition of Emalex Biosciences GuruFocusTeva to acquire Emalex in deal worth up to $900 million CTech
